C 10 H 13 Cl4N 2 Zn, monoclinic, P21/c (no. 14), a = 13.370(2) Å, b = 10.0304(14) Å, c = 17.913(2) Å, β = 93.950(4)°, V = 2396.5(6) Å 3 , Z = 4, Rgt(F) = 0.0461, wR ref (F 2 ) = 0.1038, T = 150(2) K.
Source of material
The starting materials, 2-propyl-1H-benzimidazole and zinc chloride, are commercial and used without any purification. The title compound was synthesized as follows: 0.320 g 2-propyl-1H-benzo[d]imidazole (2 mmol), was added to 20 mL 6 M hydro chloric acid at room temperature, then 0.136 g zinc chloride was added. The mixture was stirred until the zinc chloride completely dissolved. The solution was filtered and let evaporate. Three days later, colorless crystals were obtained, washed with 1 mL cold 6 M hydrochlorid acid and air-dried, yield 62.3% (based on 2-propyl-1Hbenzimidazole).
Experimental details
All H-atoms from C, N and O atoms were positioned with idealized geometry and refined isotropically (U iso (H) = 1.2Ueq(C), 1.2Ueq(N)), for all H atoms) using a riding model.
Comment
Known as organic bases, benzimidazole and their derivatives are readily to be protonated. There are some records of 1or 2-substituted benzimidazoles used as cations to counter the negative charges of tetrachloridozincate anions [5] [6] [7] [8] [9] . As shown in the figure, the asymmetric unit consists of two 2propyl-1H-benzimidazol-3-ium cations and one tetrachloridozincate anion. There is only one kind of hydrogen bonds: N-H· · · Cl, which link the cations and anions to generate a two-dimensional supramolecular structure. All bond lengths and angles of the title compound are comparable with its analogues [5] [6] [7] [8] [9] . In detail, the bonding parameter of the title cations are in perfect accord with literature known 1Hbenzo[d] imidazol-3-ium salts [10, 11] .
